+91 780-304-0404

Atrial Fibrillation Devices Market

Global Atrial Fibrillation Devices Market Size, Share & Trends Analysis Report by Product Type (Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Mapping and Recording Systems, Cardiac Monitors, and Others), By End-Use (Hospitals and Ambulatory Surgery Centers (ASCs) and Forecast 2019-2025

Published: Dec 2019 | Report Code: OMR2020006 | Category : Medical Devices | Delivery Format: /

The global atrial fibrillation devices market is estimated to grow significantly at a CAGR of 13.7% during the forecast period. The major factors contributing to the market growth include rising prevalence of atrial fibrillation coupled with the significant incidences of cardiac arrhythmias and rising demand for minimally invasive procedures. Atrial fibrillation is the most common cause of heart arrhythmia, in which, the heart beats very slowly, very fast or in an irregular way. According to the Institute for Health Metrics and Evaluation, the prevalence of atrial fibrillation in 2013 was 33.6 million, which increased up to 37.5 million in 2017. With the significant rise in geriatric population across the globe, this number is expected to increase in the near future. 

The two major strategies used for the management of atrial fibrillation include rhythm control and rate control. Rhythm control comprises the use of electrophysiological interventions which intends to convert the arrhythmia concerned with atrial fibrillation to normal sinus rhythm. While diagnosed with atrial fibrillation, the doctor recommends an electrophysiology study to better understand the way electrical signals move in the heart to make it beat. The test enables to understand and map the electrical activity in the heart, which, in turn, contributes to diagnose abnormal heart rhythms.

Segmental Outlook  

The global atrial fibrillation devices market is segmented on the basis of product type, end-use, and region. On the basis of product type, the market is sub-segmented into electrophysiology ablation catheters, electrophysiology diagnostic catheters, electrophysiology mapping and recording systems, cardiac monitors, and others. Based on the end-use, the market is divided into hospitals and ambulatory surgery centers (ASCs). 

Global Atrial Fibrillation Devices Market Share by End-Use, 2018 (%)

Global Atrial Fibrillation Devices Market Share by End-Use

Electrophysiology Mapping and Recording Systems Segment to Grow Significantly Over the Forecast Period

The electrophysiology mapping and recording systems are widely used in the laboratories in the electrophysiology methods for the management of cardiac arrhythmias. Various companies in the global atrial fibrillation market that are developing and marketing electrophysiology mapping and recording systems include GE Healthcare, Abbott Laboratories and Boston Scientific Corp. These companies are majorly contributing to the electrophysiology mapping and recording systems market by catering to a wide range of customers across the globe. 

For instance, Boston Scientific provides the LABSYSTEM PRO EP Recording System that enables the precise diagnosis of complex Arrhythmias. Additionally, GE healthcare provides the CardioLab EP Recording System that is an advanced device that provides effective information integration that drive clinical throughput in high-speed, high-volume labs. The CardioLab electrophysiology recording system is designed to optimize workflow, productivity and throughput in laboratories; thus, these advanced recording systems are widely accepted in laboratories. 

Regional Outlook 

Geographically, the study of the global atrial fibrillation devices market covers the analysis of four major regions including North America (the US and Canada), Europe (Germany, UK, Italy, France, Italy, Spain, and Rest of Europe), and Rest of the World (RoW). North America held the largest market share in the global atrial fibrillation devices market in 2018 and is further estimated to follow the same trend over the forecast period. The growing adoption of advanced technologies coupled with the well-developed healthcare infrastructure in the region is augmenting the market growth. The rising prevalence of the cardiovascular disease in the region is also driving the demand for various atrial fibrillation devices; thereby, augmenting market growth. 

Global Atrial Fibrillation Devices Market Growth, by Region 2019-2025
Global Atrial Fibrillation Devices Market Growth, by Region

Asia-Pacific is Growing at the Fastest Growth Rate During the Forecast Period

The atrial fibrillation devices market in Asia-Pacific is estimated to register the fastest growth rate over the forecast period. The growth in the region is bolstered by emerging economies including China and India, a rapid increase in the elderly population, and an increasing number of cardiac diseases. The penetration of atrial fibrillation ablation is moderate in the region and is expected to grow substantially over the forecast period. With advancing success rate enabled by new technologies, the atrial fibrillation devices market is expected to record a rapid growth in the next few years. Given the high growth potential in atrial fibrillation ablation, the Asia-Pacific atrial fibrillation market is considered a very attractive market for cardiovascular MedTech players. 

Market Players Outlook

Furthermore, the global atrial fibrillation devices market is characterized by the presence of several market players that are developing and marketing various devices to be used in atrial fibrillation treatment to cater to a wide range of customers across the globe. Some of the key players operating in the market include Abbott Laboratories Inc., Medtronic PLC, Boston Scientific Corp., Koninklijke Philips NV, Siemens AG, and others. In order to remain competitive in the market, these market players adopt various strategies such as mergers and acquisitions, product offering expansion, geographical expansion, partnerships and collaborations, and others. Players operating in the market are also focusing on the market opportunities to capture the market share. 

Recent Developments
  • In May 2019, Koninklijke Philips NV announced a collaboration with Medtronic PLC to further advance the treatment of paroxysmal atrial fibrillation, a common heart rhythm disorder. Through the agreement, Medtronic will facilitate sales of products on behalf of Philips to provide an innovative, integrated image guidance solution for cryoablation procedures. Additionally. Philips will bring the novel KODEX-EPD cardiac imaging and navigation system with cryoablation specific features to enable electrophysiologists to perform cryoablation procedures with reduced need for X-ray imaging into the market. 
  • In February 2019, Johnson & Johnson Institute partners with the electrophysiology community to fight the growing epidemic of atrial fibrillation. This includes more than 900 members of the electrophysiology community with an agenda to reflect the latest developments, research, and perspectives in the diagnosis and treatment of atrial fibrillation. This will enable the company to conduct R&D for the development of much reliable, safer and efficient electrophysiology products.
  • In May 2018, Biosense Webster Inc., a subsidiary of Johnson & Johnson Services, Inc. introduced CARTO VIZIGO Bi-directional Guiding Sheath to decrease radiation exposure and augment the efficiency of the ablation procedure. It is the first steerable guiding sheath available commercially and visualized on the CARTO 3 system during a catheter ablation procedure to enable electrophysiologists to decrease dependency on fluoroscopy. With this launch, the company sustained a strong position in the market and offers substantial market opportunities for market growth. 
  • In March 2017, Abbott Laboratories Inc. declared the US FDA approval for FlexAbility ablation catheter, sensor-enabled to increase the accuracy and versatility during cardiac ablation procedures and for the treatment of atrial flutter. Due to this approval, Abbott has widened its portfolio related to electrophysiology to effectively treat patients suffering from cardiac arrhythmias and supports physicians to solve complex cases.
The Report Covers
  • Market value data analysis of 2018 and forecast to 2025.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global atrial fibrillation devices market. Based on the availability of data, information related to products, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying ‘who-stands-where’ in the market.

1. Report Summary

1.1. Research Methods and Tools

1.2. Market Breakdown

1.2.1. By Segments

1.2.2. By Geography

2. Market Overview and Insights

2.1. Scope of the Report 

2.2. Analyst Insight & Current Market Trends

2.2.1. Key Findings

2.2.2. Recommendations

2.2.3. Conclusion

2.3. Rules & Regulations

3. Competitive Landscape

3.1. Company Share Analysis

3.2. Key Strategy Analysis

3.3. Key Company Analysis

3.3.1. Abbott Laboratories Inc.

3.3.1.1. Overview

3.3.1.2. Financial Analysis

3.3.1.3. SWOT Analysis

3.3.1.4. Recent Developments

3.3.2. Boston Scientific Corp.

3.3.2.1. Overview

3.3.2.2. Financial Analysis

3.3.2.3. SWOT Analysis

3.3.2.4. Recent Developments

3.3.3. Koninklijke Philips NV

3.3.3.1. Overview

3.3.3.2. Financial Analysis

3.3.3.3. SWOT Analysis

3.3.3.4. Recent Developments

3.3.4. Siemens AG

3.3.4.1. Overview

3.3.4.2. Financial Analysis

3.3.4.3. SWOT Analysis

3.3.4.4. Recent Developments

3.3.5. Medtronic PLC

3.3.5.1. Overview

3.3.5.2. Financial Analysis

3.3.5.3. SWOT Analysis

3.3.5.4. Recent Developments

4. Market Determinants

4.1. Motivators

4.2. Restraints

4.3. Opportunities

5. Market Segmentation

5.1. Global Atrial Fibrillation Devices Market by Product Type

5.1.1. Electrophysiology Ablation Catheters

5.1.2. Electrophysiology Diagnostic Catheters

5.1.3. Electrophysiology Mapping and Recording Systems

5.1.4. Cardiac Monitors

5.1.5. Others (Intracardiac Echocardiography (ICE) Systems)

5.2. Global Atrial Fibrillation Devices Market by End-Use

5.2.1. Hospitals and Clinics

5.2.2. Ambulatory Surgery Centers (ASCs)

6. Regional Analysis

6.1. North America

6.1.1. United States

6.1.2. Canada

6.2. Europe

6.2.1. UK

6.2.2. Germany

6.2.3. Italy

6.2.4. Spain

6.2.5. France

6.2.6. Rest of Europe

6.3. Asia-Pacific

6.3.1. China

6.3.2. Japan

6.3.3. India

6.3.4. Rest of Asia-Pacific

6.4. Rest of the World

7. Company Profiles

7.1. Abbott Laboratories Inc.

7.2. Advanced Cardiac Therapeutics, Inc.

7.3. AliveCor, Inc.

7.4. AtriCure, Inc.

7.5. AuriGen Medical

7.6. BIOTRONIK SE & Co. KG

7.7. Boston Scientific Corp.

7.8. CardioFocus, Inc.

7.9. CathRx Ltd.

7.10. General Electric Co.

7.11. Hansen Medical Inc.

7.12. Japan Lifeline Co.

7.13. Johnson and Johnson Services Inc. (Biosense Webster)

7.14. Koninklijke Philips NV

7.15. Medtronic PLC

7.16. MicroPort Scientific Corp. 

7.17. Osypka AG

7.18. Siemens AG

7.19. Stereotaxis, Inc.

7.20. Vanguard AG

7.21. Verily Life Sciences LLC

  1. GLOBAL ATRIAL FIBRILLATION DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2018-2025 ($ MILLION)
  2. GLOBAL ELECTROPHYSIOLOGY ABLATION CATHETERS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  3. GLOBAL ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  4. GLOBAL ELECTROPHYSIOLOGY MAPPING AND RECORDING SYSTEMS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  5. GLOBAL CARDIAC MONITORS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  6. GLOBAL OTHER ATRIAL FIBRILLATION DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  7. GLOBAL ATRIAL FIBRILLATION DEVICES MARKET RESEARCH AND ANALYSIS BY END-USE, 2018-2025 ($ MILLION)
  8. GLOBAL ATRIAL FIBRILLATION DEVICES IN HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  9. GLOBAL ATRIAL FIBRILLATION DEVICES IN ASC MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  10. GLOBAL ATRIAL FIBRILLATION DEVICES MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2018-2025 ($ MILLION)
  11. NORTH AMERICAN ATRIAL FIBRILLATION DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  12. NORTH AMERICAN ATRIAL FIBRILLATION DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2018-2025 ($ MILLION)
  13. NORTH AMERICAN ATRIAL FIBRILLATION DEVICES MARKET RESEARCH AND ANALYSIS BY END-USE, 2018-2025 ($ MILLION)
  14. EUROPEAN ATRIAL FIBRILLATION DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  15. EUROPEAN ATRIAL FIBRILLATION DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2018-2025 ($ MILLION)
  16. EUROPEAN ATRIAL FIBRILLATION DEVICES MARKET RESEARCH AND ANALYSIS BY END-USE, 2018-2025 ($ MILLION)
  17. ASIA-PACIFIC ATRIAL FIBRILLATION DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  18. ASIA-PACIFIC ATRIAL FIBRILLATION DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2018-2025 ($ MILLION)
  19. ASIA-PACIFIC ATRIAL FIBRILLATION DEVICES MARKET RESEARCH AND ANALYSIS BY END-USE, 2018-2025 ($ MILLION)
  20. REST OF THE WORLD ATRIAL FIBRILLATION DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2018-2025 ($ MILLION)
  21. REST OF THE WORLD ATRIAL FIBRILLATION DEVICES MARKET RESEARCH AND ANALYSIS BY END-USE, 2018-2025 ($ MILLION)
  1. GLOBAL ATRIAL FIBRILLATION DEVICES MARKET SHARE BY PRODUCT TYPE, 2018 VS 2025 (%)
  2. GLOBAL ATRIAL FIBRILLATION DEVICES MARKET SHARE BY END-USE, 2018 VS 2025 (%)
  3. GLOBAL ATRIAL FIBRILLATION DEVICES MARKET SHARE BY GEOGRAPHY, 2018 VS 2025 (%)
  4. US ATRIAL FIBRILLATION DEVICES MARKET SIZE, 2018-2025 ($ MILLION)
  5. CANADA ATRIAL FIBRILLATION DEVICES MARKET SIZE, 2018-2025 ($ MILLION)
  6. UK ATRIAL FIBRILLATION DEVICES MARKET SIZE, 2018-2025 ($ MILLION)
  7. FRANCE ATRIAL FIBRILLATION DEVICES MARKET SIZE, 2018-2025 ($ MILLION)
  8. GERMANY ATRIAL FIBRILLATION DEVICES MARKET SIZE, 2018-2025 ($ MILLION)
  9. ITALY ATRIAL FIBRILLATION DEVICES MARKET SIZE, 2018-2025 ($ MILLION)
  10. SPAIN ATRIAL FIBRILLATION DEVICES MARKET SIZE, 2018-2025 ($ MILLION)
  11. ROE ATRIAL FIBRILLATION DEVICES MARKET SIZE, 2018-2025 ($ MILLION)
  12. CHINA ATRIAL FIBRILLATION DEVICES MARKET SIZE, 2018-2025 ($ MILLION)
  13. JAPAN ATRIAL FIBRILLATION DEVICES MARKET SIZE, 2018-2025 ($ MILLION)
  14. INDIA ATRIAL FIBRILLATION DEVICES MARKET SIZE, 2018-2025 ($ MILLION)
  15. REST OF ASIA-PACIFIC ATRIAL FIBRILLATION DEVICES MARKET SIZE, 2018-2025 ($ MILLION)
  16. REST OF THE WORLD ATRIAL FIBRILLATION DEVICES MARKET SIZE, 2018-2025 ($ MILLION)
Choose License Type
    On Discount

100%
Secured Payment

Why buy from us?
  • Covers more than 15 major industries, which are further segmented into 90+ sectors
  • 65% of our clients are loyal customers
  • 120+ countries are covered in analysis
  • currently servicing 1000+ customers globally
  • 100+ paid data sources mined to research
  • Our expert team will assist you with all research need and customization
  • Our expert research analyst will resolve your every query before and after purchasing the report
Related Reports